Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions
Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions
复制标题
DOI：
10.1016/j.jcmg.2016.09.031
复制
发表时间：
2017-03-01
影响因子：
14
通讯作者：
Blanke, Philipp
中科院分区：
文献类型：
--
作者：
Leipsic, Jonathon;Bax, Jeroen J.;Blanke, Philipp
通过多年的研究和验证，影像学在心脏瓣膜病诊断中的作用已得到充分确立。然而，影像学在指导心脏瓣膜病治疗决策中的作用还不太明确，而且帮助做出这些决定的随机试验数据非常缺乏。鉴于这种相对缺乏随机试验数据，本文强调了一些最重要的知识差距，并为该领域定义了有意义的机会，以帮助以具有成本效益的方式推进心脏瓣膜病患者的护理。(The合作伙伴3-试验：SAPIEN 3经导管心脏瓣膜在低风险主动脉瓣狭窄患者中的安全性和有效性[P3]; NCT 02675114; Medtronic经导管主动脉瓣置换术在低风险患者中的应用; NCT 02701283）（美国心脏病学会基金会J Am科尔Cardiolomg（C）2017。
The role of imaging in the diagnosis of valvular heart disease is well established through years of investigation and validation. However, the role of imaging in guiding the treatment decision-making for valvular heart disease is less well established, and there is a striking paucity of randomized trial data to help inform these decisions. Given this relative absence of randomized trial data, the present article highlights some of the most important knowledge gaps and defines meaningful opportunities for the field to help advance the care of patients with valvular heart disease in a cost-effective fashion. (The PARTNER 3-Trial: The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis [P3]; NCT02675114; Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT02701283) (J Am Coll Cardiolomg (C) 2017 by the American College of Cardiology Foundation.